Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1Y4L

Crystal structure of Bothrops asper myotoxin II complexed with the anti-trypanosomal drug suramin

1Y4L の概要
エントリーDOI10.2210/pdb1y4l/pdb
関連するPDBエントリー1CLP
分子名称Phospholipase A2 homolog 2, 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL, ISOPROPYL ALCOHOL, ... (5 entities in total)
機能のキーワードbothrops asper myotoxin ii, anti-trypanosomal drug suramin, hydrolase
由来する生物種Bothrops asper (terciopelo)
細胞内の位置Secreted: P24605
タンパク質・核酸の鎖数2
化学式量合計29778.80
構造登録者
Murakami, M.T.,Arruda, E.Z.,Melo, P.A.,Martinez, A.B.,Calil-Elias, S.,Tomaz, M.A.,Lomonte, B.,Gutierrez, J.M.,Arni, R.K. (登録日: 2004-12-01, 公開日: 2005-06-28, 最終更新日: 2024-11-06)
主引用文献Murakami, M.T.,Arruda, E.Z.,Melo, P.A.,Martinez, A.B.,Calil-Elias, S.,Tomaz, M.A.,Lomonte, B.,Gutierrez, J.M.,Arni, R.K.
Inhibition of Myotoxic Activity of Bothrops asper Myotoxin II by the Anti-trypanosomal Drug Suramin.
J.Mol.Biol., 350:416-426, 2005
Cited by
PubMed Abstract: Suramin, a synthetic polysulfonated compound, developed initially for the treatment of African trypanosomiasis and onchocerciasis, is currently used for the treatment of several medically relevant disorders. Suramin, heparin, and other polyanions inhibit the myotoxic activity of Lys49 phospholipase A2 analogues both in vitro and in vivo, and are thus of potential importance as therapeutic agents in the treatment of viperid snake bites. Due to its conformational flexibility around the single bonds that link the central phenyl rings to the secondary amide backbone, the symmetrical suramin molecule binds by an induced-fit mechanism complementing the hydrophobic surfaces of the dimer and adopts a novel conformation that lacks C2 symmetry in the dimeric crystal structure of the suramin-Bothrops asper myotoxin II complex. The simultaneous binding of suramin at the surfaces of the two monomers partially restricts access to the nominal active sites and significantly changes the overall charge of the interfacial recognition face of the protein, resulting in the inhibition of myotoxicity.
PubMed: 15961104
DOI: 10.1016/j.jmb.2005.04.072
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.7 Å)
構造検証レポート
Validation report summary of 1y4l
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon